Casi Pharmaceuticals(CASI)
CASI Pharmaceuticals, previously known as EntreMed is a US based pharmaceutical company developing medicinal treatments for cancer. The company is primarily known for its producing the angiogenesis inhibitor Endostatin. In 2014 the company was renamed to CASI Pharmaceuticals to focus on the products for the treatments of myeloma, leukemia, lymphoma. Wei-Wu He is the present chairman and CEO of the company.